
CVS Preview: Still About Maintenance Choice

By Brian Gilmartin
About this article:
CVS Caremark is scheduled to report third-quarter earnings before the bell on Thursday, and consensus expectations are looking for EPS of 64 cents, for year-over-year growth of 6.5%, on $24.6 billion in revenue, for year-over-year growth of 18%. (The third-quarter 2008 revenue number may not be a proper comparison given that it is highly likely that the Longs drugstore acquisition is not included, since it didn't close until after third quarter 2008.)
It has been interesting to watch the steel-cage match between Walgreen and CVS over the past 15 years. Walgreen was the clear outperformer in the 1990s, thanks to organic growth and what was thought to be the better model, but CVS has been the better performer for most of this decade, although the company model changed dramatically with the acquisition of Caremark pharmacy benefit management (PBM) a few years ago.
For this quarter, the...

Or, call us at 1-866-321-TSCM (8726) Monday-Friday, 8 a.m.-6 p.m. ET.
Outside the U.S. and in Canada, call 1-212-321-5200.
|
|
|

 |

If you decide to subscribe and you're not completely satisfied with TheStreet.com RealMoney, just call us within the first 30 days of your subscription and we'll refund your full annual subscription price — guaranteed.
|
|
|
|
|
If you choose a 14-day free trial of RealMoney and you do NOT call to cancel within those 14 days, you will pay $129.95 — a $100 savings off the regular annual subscription price of $229.95. Unless you cancel before the end of that year, your subscription will automatically renew for another year at the then-current subscription price.
Offer applies only to new annual subscriptions, and is subject to change at any time. Void where prohibited.
If you choose a monthly subscription, you pay $34.95 per month. You will be notified if the current monthly rate of $34.95 changes at any time in the future.
TheStreet.com is a publisher. None of the contributors or their affiliates will provide you with personally tailored advice concerning the nature, potential, value or suitability of any particular security, portfolio of securities, transaction, investment strategy or other matter. From time to time, any or all of the contributors or their affiliates may hold positions in securities mentioned and they may trade for their own accounts. In cases where the position is held at the time of publication, appropriate disclosure is made.
© TheStreet.com, Inc., 14 Wall Street, 15th Floor, New York, NY 10005.
|